Dosley guides

Ozempic vs Wegovy: what's actually different

Compare high-level Ozempic and Wegovy label topics, organize questions, and understand what an educational overview cannot decide for you.

Author
Stefan Creanga, Dosley developer
Last reviewed
Review method
Source and boundary checks

Ozempic vs Wegovy is a common search because both brand names are tied to semaglutide. The important distinction is that “same active ingredient” does not mean “same label, same approved use, same device, or interchangeable prescription.” (Ozempic PI; Wegovy PI)

This guide compares label facts only. It does not tell you which medication to take, whether to switch, or how to change a dose.

Quick comparison

TopicOzempicWegovy
Active ingredientSemaglutide (ref)Semaglutide (ref)
Label focusAdults with type 2 diabetes, including specified cardiovascular and kidney-risk indications (ref)Weight reduction and maintenance, cardiovascular-risk reduction in adults with established cardiovascular disease and obesity or overweight, and a MASH indication under accelerated approval (ref)
Injection timingOnce weekly (ref)Once weekly for injection (ref)
Injection regions listedAbdomen, thigh, or upper arm (ref)Abdomen, thigh, or upper arm (ref)
Product presentationMulti-dose single-patient-use pens and single-dose prefilled syringes are listed in the current label (ref)The current label covers Wegovy injection and Wegovy tablets (ref)

Every row above comes from a label, not from a comparison of how well either one works.

Same active ingredient, different approved uses

Ozempic’s current label says it is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The same label also lists risk-reduction indications for major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and for kidney disease progression and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. (Ozempic PI)

Wegovy’s current label says Wegovy injection is indicated with reduced-calorie diet and increased physical activity to reduce major adverse cardiovascular event risk in adults with established cardiovascular disease and obesity or overweight, to reduce excess body weight and maintain weight reduction long term in specified adults and adolescents, and to treat noncirrhotic MASH with moderate to advanced liver fibrosis under accelerated approval. (Wegovy PI)

Those label differences are why a prescriber decision matters. A comparison article can describe approved uses; it cannot decide which approved use applies to you.

Injection routine similarities

Both labels describe weekly subcutaneous injection for the injectable product and list the abdomen, thigh, or upper arm as injection regions. The Ozempic label says to use a different injection site each week when injecting in the same body region. The Wegovy label says to rotate injection sites with each dose. (Ozempic PI; Wegovy PI)

If you are tracking a weekly routine, those shared categories matter: date, product, prescribed dose, and injection body region. For the broader routine, see the GLP-1 injection guide.

Product presentation is different

Ozempic’s current prescribing information lists multi-dose single-patient-use pens. The dose-count table is why people ask how long a pen lasts. See How long does an Ozempic pen last? for that label-based arithmetic. (Ozempic PI)

Wegovy’s current prescribing information covers Wegovy injection and Wegovy tablets. This guide does not compare tablet routines or suggest switching between presentations. Use the current label and your prescriber’s instructions for the exact product you have. (Wegovy PI)

Missed-dose language is product-specific

Do not assume a missed-dose rule is interchangeable just because two products contain semaglutide. The two labels use different windows, and Wegovy’s injection and tablet instructions differ from each other. The missed GLP-1 dose guide reproduces both labels’ wording verbatim, with attribution, and explains why Dosley records the event instead of telling you what to do. (Ozempic PI; Wegovy PI)

After the prescription decision

Dosley does not help you choose between these two. It helps once the choice is made and the weekly routine starts. Which brand, which pen strength, which day, which body region. If you switch from one to the other, the injection dates on either side of the change are worth having in front of you at the next appointment.

For medication-specific background, see Dosley’s Ozempic and Wegovy pages.

Questions covered in this guide

Are Ozempic and Wegovy the same medication?

They share one active ingredient, semaglutide, but they are not the same medication. Each has its own prescribing information, its own approved uses, and its own product presentations. Treating the two brand names as interchangeable is where most of the confusion starts. [1] [2]

Can this guide tell me which one to take?

No. This guide compares label facts only. Which medication is appropriate is a prescriber decision.

Track your routine

Keep injection notes, symptoms, weight, and pen supply together.

Open the GLP-1 tracker page

References

  1. Ozempic (semaglutide) injection prescribing information Novo Nordisk Revised 05/2026
  2. Wegovy (semaglutide) injection and tablets prescribing information Novo Nordisk Revised 06/2026